Clinical Trial Update: Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating secondary cytoreductive surgery after chemotherapy for recurrent epithelial ovarian cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Ovarian Cancer | Phase 2 | Status: RECRUITING